Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Evaluate the Pharmacokinetics and Safety of INX-08189 Administered With VictrelisTM in Healthy Subjects (INX-189-004)
This study has been completed.
Study NCT01471717   Information provided by Bristol-Myers Squibb

First Received on November 3, 2011.   Last Updated on June 21, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Interventions listed in this trial
INX-08189 50 mg QD X 5 days
Victrelis 800 mg TID x 3 days
Placebo with Victrelis 800 mg
Sponsors listed in this trial
Bristol-Myers Squibb


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services